Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Letter
Nature Medicine 9, 1323–1326 (1 October 2003) | doi:10.1038/nm935
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist
&
Abstract
The polycystic kidney diseases (PKDs) are a group of genetic disorders causing significant renal failure and death in children and adults. There are no effective treatments.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
